Louise Møller Jørgensen
◽
Anders Ohlhues Baandrup
◽
Joseph Mandeville
◽
Andreas Nørgaard Glud
◽
Jens Christian Hedemann Sørensen
◽
...
Abstract
BackgroundElectroceutical therapy, applied in various forms, is a rapidly growing therapeutic option to be considered across different medical disorders, particularly within psychiatry, neurology, chronic pain and rehabilitation therapy. Combining targeted electric stimuli with feedback from fMRI can provide valuable information about the mechanisms underlying the therapeutic effects. So far, however, such studies have been hampered by the lack of technology to conduct such experiments in a both accurate and safe manner. We here present a patented system, a fMRI compatible electrical stimulator, developed for fMRI data acquisition during deep brain stimulation (DBS), as well as the first proof-of-concept neuroimaging data in pigs obtained with a prototype of the device.MethodsThe system consists of two modules, placed in the control and scanner room, with corresponding optical modules and signal converters, connected by optical fiber led through wave guides and back looped for quality assurance. The system is also connected to the MRI scanner to timely initiate the stimulation sequence at start of scan. We evaluated the system in four pigs with DBS in the subthalamic nucleus (STN) where we acquired the BOLD response in the STN and neocortex, with stimulation turned on and off in a block design synchronized to the scanning sequence.ResultsWe found that the system delivered a robust electrical stimulus to the implanted electrode during the entire experimental period. The stimulus was confirmed to be in sync with the preprogrammed fMRI block design. All pigs displayed a DBS-STN induced neocortical BOLD response, but none in the site of the implanted electrode. The system solves three major problems related to electrical stimuli and fMRI examinations, namely preventing distortion of the fMRI signal, enabling communication that synchronize the experimental conditions, and surmounting the safety hazards caused by interference from the powerful magnetic field and RF emission. ConclusionsThe patented fMRI compatible electrical stimulator, based on an optic fiber solution, circumvents previous problems related to DBS electroceuticals and fMRI. The system allows flexible modifications for fMRI designs and stimulation parameters but can also be customized to electroceutical applications beyond DBS, applicable for a broad range of medical conditions.